Literature DB >> 22344354

Infection profile of patients undergoing autologous bone marrow transplantation in a Brazilian institution.

Kelli Borges Santos1, Abrahão Elias Hallack Neto, Girlene Alves Silva, Angelo Atalla, Marcus Matta Abreu, Luiz Cláudio Ribeiro.   

Abstract

CONTEXT AND
OBJECTIVE: Hematopoietic stem cell transplantation (HSCT) has been widely used for treating oncological and hematological diseases. Although HSCT has helped to improve patient survival, the risk of developing infection during hospitalization is an important cause of morbidity and mortality. This study aimed to analyze the infection profile during hospitalization and the associated risk factors among patients undergoing autologous HSCT at the University Hospital, Universidade Federal de Juiz de Fora. DESIGN AND
SETTING: This was a cross-sectional study on patients undergoing autologous HSCT at a public university hospital.
METHODS: Patients with febrile neutropenia between 2004 and 2009 were retrospectively evaluated regarding their infection profile and associated risk factors.
RESULTS: Infection occurred in 57.2% of 112 patients with febrile neutropenia. The main source of infection was the central venous catheter (25.9%). Infection was chiefly due to Gram-positive bacteria, although Gram-negative-related infections were more severe and caused a higher death rate. Sex, age, skin color, nutritional status and underlying disease were not associated with the development of infection. Patients with severe mucositis (Grades III and IV) had a higher infection rate (P < 0.001). Patients who developed pulmonary complications during hospitalization had higher infection rates (P = 0.002). Infection was the main cause of death (57.1%) in the study sample.
CONCLUSION: Strategies aimed at reducing infection-related mortality rates among patients undergoing autologous HSCT are necessary.

Entities:  

Mesh:

Year:  2012        PMID: 22344354     DOI: 10.1590/s1516-31802012000100003

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  3 in total

1.  Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.

Authors:  K B dos Santos; L J Costa; A Atalla; J Pereira; A E Hallack-Neto
Journal:  Bone Marrow Transplant       Date:  2014-06-02       Impact factor: 5.483

2.  Analysis of the feasibility of early hospital discharge after autologous hematopoietic stem cell transplantation and the implications to nursing care.

Authors:  Alessandra Barban; Fabio Luiz Coracin; Priscila Tavares Musqueira; Andrea Barban; Lilian Piron Ruiz; Milton Artur Ruiz; Rosaura Saboya; Frederico Luiz Dulley
Journal:  Rev Bras Hematol Hemoter       Date:  2014-05-29

3.  Infectious diarrhea in autologous stem cell transplantation: high prevalence of coccidia in a South American center.

Authors:  Marcelo Dias de Castro; Julio Maria Chebli; Luciano José Costa; Katia Regina Lopes Alves; Angelo Atalla; Abrahao E Hallack Neto
Journal:  Hematol Transfus Cell Ther       Date:  2018-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.